BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18426988)

  • 1. Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction.
    Devine SM; Vij R; Rettig M; Todt L; McGlauchlen K; Fisher N; Devine H; Link DC; Calandra G; Bridger G; Westervelt P; Dipersio JF
    Blood; 2008 Aug; 112(4):990-8. PubMed ID: 18426988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.
    Burroughs L; Mielcarek M; Little MT; Bridger G; Macfarland R; Fricker S; Labrecque J; Sandmaier BM; Storb R
    Blood; 2005 Dec; 106(12):4002-8. PubMed ID: 16105977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization as a preparative regimen for hematopoietic stem cell transplantation.
    Chen J; Larochelle A; Fricker S; Bridger G; Dunbar CE; Abkowitz JL
    Blood; 2006 May; 107(9):3764-71. PubMed ID: 16439683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.
    Hoggatt J; Singh P; Tate TA; Chou BK; Datari SR; Fukuda S; Liu L; Kharchenko PV; Schajnovitz A; Baryawno N; Mercier FE; Boyer J; Gardner J; Morrow DM; Scadden DT; Pelus LM
    Cell; 2018 Jan; 172(1-2):191-204.e10. PubMed ID: 29224778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.
    Saraceni F; Shem-Tov N; Olivieri A; Nagler A
    Bone Marrow Transplant; 2015 Jul; 50(7):886-91. PubMed ID: 25665044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
    Cojoc M; Peitzsch C; Trautmann F; Polishchuk L; Telegeev GD; Dubrovska A
    Onco Targets Ther; 2013 Sep; 6():1347-61. PubMed ID: 24124379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.
    Chen YB; Le-Rademacher J; Brazauskas R; Kiefer DM; Hamadani M; DiPersio JF; Litzow MR; Craig M; Horwitz ME; Artz AS; McClune BL; Fernandez HF; Duong HK; Kobusingye H; Proue M; Drexler RJ; Horowitz MM; Shaw BE; Miller JP; Hosoba S; Waller EK; Devine SM
    Blood Adv; 2019 Mar; 3(6):875-883. PubMed ID: 30890544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
    Green MM; Chao N; Chhabra S; Corbet K; Gasparetto C; Horwitz A; Li Z; Venkata JK; Long G; Mims A; Rizzieri D; Sarantopoulos S; Stuart R; Sung AD; Sullivan KM; Costa L; Horwitz M; Kang Y
    J Hematol Oncol; 2016 Aug; 9(1):71. PubMed ID: 27535663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges.
    Prisciandaro M; Santinelli E; Tomarchio V; Tafuri MA; Bonchi C; Palazzo G; Nobile C; Marinucci A; Mele M; Annibali O; Rigacci L; Vacca M
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy?
    Cismaru CA; Tomuleasa C; Jurj A; Chira S; Isachekcu E; Cismaru G; Gherman LM; Gulei D; Munteanu R; Berindan Neagoe I
    Stem Cell Rev Rep; 2024 Jan; 20(1):206-217. PubMed ID: 37922107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation.
    Salhotra A; Yuan S; Ali H
    Front Oncol; 2023; 13():1196564. PubMed ID: 37700828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.
    Canarutto D; Omer Javed A; Pedrazzani G; Ferrari S; Naldini L
    Br Med Bull; 2023 Sep; 147(1):108-120. PubMed ID: 37460391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.
    Crees ZD; Rettig MP; Bashey A; Devine SM; Jaglowski S; Wan F; Zhou A; Harding M; Vainstein-Haras A; Sorani E; Gliko-Kabir I; Grossman BJ; Westervelt P; DiPersio JF; Uy GL
    Blood Adv; 2023 Sep; 7(18):5210-5214. PubMed ID: 37327120
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy.
    Leo M; Sabatino L
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease.
    Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of plerixafor in poorly mobilized allogeneic stem cell donors.
    Zhuang L; Lauro D; Wang S; Yuan S
    J Clin Apher; 2022 Aug; 37(4):388-394. PubMed ID: 35633513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma.
    Patterson AM; Zhang S; Liu L; Li H; Singh P; Liu Y; Farag SS; Pelus LM
    Stem Cell Rev Rep; 2021 Dec; 17(6):2124-2138. PubMed ID: 34510361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
    Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
    BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update.
    Bilgin YM
    J Blood Med; 2021; 12():403-412. PubMed ID: 34104027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CXCR4 in the progression and therapy of acute leukaemia.
    Su L; Hu Z; Yang YG
    Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.